Osaic Holdings’s Lucid Diagnostics LUCD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$26.2K Buy
22,770
+5,360
+31% +$6.82K ﹤0.01% 5690
2025
Q4
$19K Hold
17,410
﹤0.01% 5913
2025
Q3
$21.2K Buy
17,410
+7,475
+75% +$8.16K ﹤0.01% 5893
2025
Q2
$11.4K Buy
9,935
+9,908
+36,696% +$12.8K ﹤0.01% 6070
2025
Q1
$39 Sell
27
-3,026
-99% -$3.63K ﹤0.01% 7309
2024
Q4
$2.5K Sell
3,053
-15
-0.5% -$13 ﹤0.01% 6518
2024
Q3
$2.5K Buy
3,068
+3,026
+7,205% +$2.48K ﹤0.01% 6516
2024
Q2
$33 Sell
42
-3
-7% -$3 ﹤0.01% 7321
2024
Q1
$35 Sell
45
-1,955
-98% -$2.54K ﹤0.01% 7097
2023
Q4
$2.82K Hold
2,000
﹤0.01% 6395
2023
Q3
$2.34K Hold
2,000
﹤0.01% 6579
2023
Q2
$2.78K Hold
2,000
﹤0.01% 6543
2023
Q1
$2.8K Buy
2,000
+1,000
+100% +$1.39K ﹤0.01% 6585
2022
Q4
$1K Buy
1,000
+678
+211% +$1.22K ﹤0.01% 6907
2022
Q3
$0 Sell
322
-230
-42% -$572 ﹤0.01% 7409
2022
Q2
$1K Buy
+552
New +$1.23K ﹤0.01% 7107

Other funds holding LUCD

Osaic Holdings's LUCD Position: Q1 2026 in Review

Osaic Holdings increased its Lucid Diagnostics (LUCD) stake by 31% in Q1 2026, buying an estimated $6.82K and bringing the position to 22,770 shares worth $26.2K. The position accounts for ﹤0.01% of the portfolio, ranked #5690.

Osaic Holdings first reported a position in LUCD in Q2 2022 and has held it in 16 quarters since. 103 funds tracked by Wall St. Rank hold LUCD as of Q1 2026.

  • Osaic Holdings held 22,770 shares of Lucid Diagnostics worth $26.2K as of Q1 2026.
  • Osaic Holdings bought 5,360 Lucid Diagnostics shares in Q1 2026, an estimated $6.82K.
  • Lucid Diagnostics made up ﹤0.01% of Osaic Holdings's portfolio in Q1 2026, its #5690 holding.
  • Osaic Holdings first reported a position in Lucid Diagnostics in Q2 2022 and has held it in 16 quarters since.
  • 103 funds tracked by Wall St. Rank held Lucid Diagnostics as of Q1 2026.

Based on Osaic Holdings's 13F filing for Q1 2026, filed 15 May 2026.